Scilex Holding (SCLX) Preferred Dividend Payments (2025 - 2026)
Scilex Holding (SCLX) posted Preferred Dividend Payments of -$1.2 million for Q2 2026, down 2514.89% on a QoQ basis from -$47000.0 in Q4 2025, and up 97.19% year-over-year from -$623253.4 in Q2 2025.
Powered by 
Analysis
Scilex Holding (SCLX) Preferred Dividend Payments (2025 - 2026) Analysis & Trends
Scilex Holding has reported Preferred Dividend Payments for 2 years, with the latest figure at -$1.2 million in Q2 2026.
- On a quarterly basis, Preferred Dividend Payments rose 97.19% year-over-year to -$1.2 million in Q2 2026; TTM through Jun 2026 was -$45.0 million, a 2.92% decrease from a year earlier, with the FY2025 full-year figure at -$43.8 million, changed N/A from the prior year.
- Preferred Dividend Payments was -$1.2 million for Q2 2026 at Scilex Holding, down from -$47000.0 in the prior quarter.
- The five-year high for Preferred Dividend Payments was -$47000.0 in Q4 2025, with the low at -$43.8 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | - |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | Scilex Holding | 35.91 Mn | -76.88 Mn | 3.97 Mn | -1.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.23 Mn |
| Dec 31, 2025 | -47,000.00 |
| Jun 30, 2025 | -43.75 Mn |